Brief: Lund University Finances And Conducts Clinical Study Together With Carbiotix Axos Medical Food
03/04/2020 12:04
April 3 (Reuters) - Carbiotix AB (publ) CRBX.TE :
* LUND UNIVERSITY FINANCES AND CONDUCTS CLINICAL STUDY
TOGETHER
WITH CARBIOTIX AXOS MEDICAL FOOD
* ANNOUNCES TODAY THAT LUND UNIVERSITY, WORKING WITH SKÅNE
UNIVERSITY HOSPITAL, HAS BEEN GRANTED FUNDING TO CONDUCT A
FOUR-MONTH CLINICAL STUDY OF 100 TYPE2 DIABETES PATIENTS DURING
Q2 2021 USING CARBIOTIX AXOS MEDICAL FOOD AS A CO-TREATMENT TO
DRUG METFORMIN
* RESULTS OF STUDY TO PROVIDE KEY CLINICAL DATA FOR
REGULATORY
APPROVALS IN US AND EUROPE AND EVIDENCE FOR POTENTIAL COMMERCIAL
LAUNCH OF METFORMIN MEDICAL FOOD CO-TREATMENT PRODUCT TARGETING
DIABETES PATIENTS IN EARLY 2022
Source text for Eikon: ID:nWkr48vVkK
Further company coverage: CRBX.TE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Carbiotix AB (publ)
See all newsBrief: Carbiotix Accelerates JCDA Timeline With Date Producer
Brief: Carbiotix AB Publishes Outcome Of Rights Issue
Brief: Carbiotix Says Co Receives Additional Guarantee Commitments In Ongoing Rights Issue Of Units
Brief: Carbiotix Receives Gras Regulatory Approval For Carbiaxos
Brief: Carbiotix AB Says Board Decides On Preferential Issue Of Units In Order Complete The GRAS SA Process And Accelerate Sales Of Carbiaxos